首页> 外文期刊>Pediatric Pulmonology >Catecholamine alterations in pediatric obstructive sleep apnea: effect of obesity.
【24h】

Catecholamine alterations in pediatric obstructive sleep apnea: effect of obesity.

机译:儿茶酚胺改变对小儿阻塞性睡眠呼吸暂停的影响:肥胖的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

STUDY OBJECTIVES: Obstructive sleep apnea (OSA) elicits increased sympathetic activity in adults and increased urinary catecholamines. Moreover, urinary catecholamine excretion is altered in obese patients. We hypothesized that morning urine catecholamine levels would be correlated with the severity of obstructive sleep apnea and degree of obesity in children. METHODS: Children referred to the pediatric sleep center for habitual snoring underwent overnight polysomnography, and the first morning voided urine sample was collected. Urinary concentrations of norepinephrine, epinephrine and dopamine were measured and corrected for creatinine levels. In a subset of children, blood samples were drawn and gene expression of catecholamine-relevant genes analyzed by quantitative real-time PCR. RESULTS: One hundred fifty-nine children were recruited and completed the protocol. Children with OSA had significantly higher urinary norepinephrine and epinephrine levels, but not dopamine, compared to habitual snorers (norepinephrine: 40.1 +/- 24.7 ng/mg creatinine vs. 31.6 +/- 16.2 ng/mg creatinine, P < 0.01; epinephrine: 6.4 +/- 10.5 ng/mg vs. 4.5 +/- 0.5 ng/mg, P < 0.01). There was a positive correlation between norepinephrine and epinephrine values and polysomnographic indices, but no effect of obesity on catecholamine levels. In addition, expression of several of the major genes involved in synthesis and transport of catecholamines, as well as in selected receptors were compatible with increased bioavailability of catecholamines. CONCLUSIONS: In children with OSA, morning urinary norepinephrine and epinephrine levels are significantly higher than those without OSA, and correlate with the severity of the disease. Gene expression patterns are in agreement with such findings. Urine catecholamine levels do not appear to be influenced by the presence of obesity. Thus, altered sympathetic activity in OSA patients appears to occur independently of the presence of obesity.
机译:研究目的:阻塞性睡眠呼吸暂停(OSA)引起成人交感神经活动增加和尿儿茶酚胺增加。此外,肥胖患者尿儿茶酚胺的排泄发生改变。我们假设早晨尿儿茶酚胺水平与儿童阻塞性睡眠呼吸暂停的严重程度和肥胖程度有关。方法:将儿童转至儿科睡眠中心进行习惯性打s的过夜通宵多导睡眠图,并收集第一天早晨排尿的尿液样本。测量了去甲肾上腺素,肾上腺素和多巴胺的尿液浓度并校正了肌酐水平。在一部分儿童中,抽取了血液样本,并通过定量实时PCR分析了儿茶酚胺相关基因的基因表达。结果:招募了159名儿童并完成了方案。与习惯性打者相比,患有OSA的儿童尿中去甲肾上腺素和肾上腺素水平显着更高,但多巴胺没有升高(去甲肾上腺素:40.1 +/- 24.7 ng / mg肌酐与31.6 +/- 16.2 ng / mg肌酐,P <0.01;肾上腺素: 6.4 +/- 10.5 ng / mg对4.5 +/- 0.5 ng / mg,P <0.01)。去甲肾上腺素和肾上腺素的值与多导睡眠图指数之间呈正相关,但肥胖对儿茶酚胺水平没有影响。另外,参与儿茶酚胺的合成和运输以及选定受体的几种主要基因的表达与儿茶酚胺的生物利用度增加相容。结论:在患有OSA的儿童中,早晨尿中去甲肾上腺素和肾上腺素的水平显着高于没有OSA的儿童,并且与疾病的严重程度相关。基因表达模式与这些发现相符。尿儿茶酚胺水平似乎不受肥胖症的影响。因此,OSA患者的交感神经活动改变似乎独立于肥胖的存在而发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号